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The leading causes of vision impairment and blindness are pos-
terior segment-related diseases including age-related macular
degeneration, diabetic macular edema and endophthalmitis.
Recently, pharmaceutical approaches to these diseases have
used steroids and oligonucleotides.These drugs are usually ad-
ministered via invasive injection because noninvasive delivery
method such as eye drop administration of drugs is not avail-
able. However, repeated injections are associated with potential
risks of complications. Moreover, patients may not comply with
such regimens. Thus, there is a pressing need for noninva-
sive delivery systems targeting the posterior segment of the
eye. In previous studies, we have reported the potential of li-
posomal eye drop formulation composed of submicron-sized
liposomes (ssLip) as a novel system for delivering drugs to the
posterior segment of the eye, including the retina [1,2]. In a
series of our studies using ssLips containing a fluorescence
marker, coumarin-6, the die was shown to be delivered into
the retina after eyedrop administration in mice, rabbits, and
monkeys [2].The purpose of this study was to improve the drug
delivery efficiency to the retina by folate-modification of lipo-
somes.We designed folate-modified ssLip (FA-modified ssLip)
to aim at selective targeting of the folic acid receptor, which
is expressed on retinal pigment epithelia cells. This active tar-
geting may lead to increase in the delivery efficiency of the
liposomal systems.
The ssLip containing coumarin-6 was prepared using hy-
dration method, and the folate ligand was inserted into
preformed liposomes by the post insertion technique [3]. A
single dose of 3 μL of the liposomal formulation was dropped
onto the left eye of mice.The mice were then sacrificed 15, 30,
60, 120, 180, 240 min after the administration of the lipo-
somal formulation. Frozen section of the enucleated eyes was
prepared with a cryostat. Images were obtained using an
epifluorescence microscope and were analyzed using Image J
software. Fig. 1 shows the typical epifluorescence micro-
scopic images of the retina 0, 30, 120 min after eyedrop
administration.To estimate the delivery efficiency to the retina,
the magnitude of fluorescence emission in the inner
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plexiform layer (IPL) of the retina was quantified using Image
J software. The fluorescence intensity of unmodified ssLip
showed the maximal value at 15–30 min, thereafter pro-
nounced decrease was observed up to 120 min. On the other
hand, FA-modified ssLip showed the higher intensity whole
range of the period after the administration compared to that
of unmodified ssLip. Besides, the liposomes tested in ocular
cells showed little cytotoxicity. The FA-modification of lipo-
somes may advance the delivery efficiency of compounds to
the retina.
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Fig. 1 – Epifluorescence microscopic images of the retina
after definite intervals of eyedrop administration. (a–c)
Unmodified ssLip, (d–f) FA-modified ssLip.
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